Tivicay Pd

Active Ingredient(s): Dolutegravir Sodium
FDA Approved: * June 12, 2020
Pharm Company: * VIIV HLTHCARE
Category: HIV / AIDS

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Tivicay Pd Overview

Dolutegravir (DTG), sold under the brand name Tivicay, is an antiretroviral medication used, together with other medication, to treat HIV/AIDS.[3] It may also be used, as part of post exposure prophylaxis, to prevent HIV infection following potential exposure.[4] It is taken by mouth.[3] Common side effects include trouble sleeping, feeling tired, diarrhea, high blood sugar, and headache.[4] Severe side effects may include allerg...

Read more Tivicay Pd Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Dolutegravir

Recent Tivicay Pd Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Tivicay Pd: (1 result)

Sorted by National Drug Code

• 49702-255 Tivicay Pd 5 mg Oral Tablet, for Suspension by Viiv Healthcare Company

Other drugs which contain Dolutegravir Sodium or a similar ingredient: (2 results)

• DOLUTEGRAVIR
• TIVICAY Dolutegravir1 discussion

Related Tivicay Pd Topics: